Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von PapaSmurf 

AC Immune Ltd diskutieren

AC Immune Ltd

WKN: A2AR5F / Symbol: ACIU / Name: AC Immune / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /

2,70 €
-2,37 %

Sell AC Immune Ltd

Einschätzung Buy
Rendite (%) 15,23 %
Kursziel 14,57
Veränderung
Endet am 20.04.24

AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) 14,95 %
Kursziel 14,55
Veränderung
Endet am 07.08.24

AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,12 %
Kursziel 14,96
Veränderung
Endet am 13.11.24

AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) -60,92 %
Kursziel 7,35
Veränderung
Endet am 31.05.25

AC Immune SA (NASDAQ: ACIU) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) -35,93 %
Kursziel 14,38
Veränderung
Endet am 18.09.25

AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,99 %
Kursziel 14,94
Veränderung
Endet am 06.11.25

AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,06 %
Kursziel 15,15
Veränderung
Endet am 15.11.25

AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) 25,64 %
Kursziel 14,75
Veränderung
Endet am 14.03.26

AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) 66,98 %
Kursziel 14,65
Veränderung
Endet am 03.04.26

AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) 78,95 %
Kursziel 10,61
Veränderung
Endet am 01.05.26

AC Immune SA (NASDAQ: ACIU) had its price target lowered by analysts at HC Wainwright from $16.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) 44,89 %
Kursziel 6,83
Veränderung
Endet am 08.09.26

AC Immune (NASDAQ:ACIU) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,75 %
Kursziel 6,95
Veränderung
Endet am 04.11.26

AC Immune (NASDAQ:ACIU) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat